These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Daikos GL; Markogiannakis A Clin Microbiol Infect; 2011 Aug; 17(8):1135-41. PubMed ID: 21635663 [TBL] [Abstract][Full Text] [Related]
29. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523 [TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Klebsiella spp. to tigecycline and other selected antibiotics. Sekowska A; Gospodarek E Med Sci Monit; 2010 Jun; 16(6):BR193-6. PubMed ID: 20512088 [TBL] [Abstract][Full Text] [Related]
31. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482 [TBL] [Abstract][Full Text] [Related]
32. Over-treatment of carbapenemase-producing Enterobacteriaceae. Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121 [TBL] [Abstract][Full Text] [Related]
33. [First isolation of KPC in Chile: from Italy to a public hospital in Santiago]. Cifuentes M; García P; San Martín P; Silva F; Zúñiga J; Reyes S; Rojas R; Ponce R; Quintanilla R; Delpiano L; Wolff M Rev Chilena Infectol; 2012 Apr; 29(2):224-8. PubMed ID: 22689041 [TBL] [Abstract][Full Text] [Related]
35. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285 [TBL] [Abstract][Full Text] [Related]
36. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Nordmann P; Cuzon G; Naas T Lancet Infect Dis; 2009 Apr; 9(4):228-36. PubMed ID: 19324295 [TBL] [Abstract][Full Text] [Related]
37. Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark. Hammerum AM; Hansen F; Lester CH; Jensen KT; Hansen DS; Dessau RB Int J Antimicrob Agents; 2010 Jun; 35(6):610-2. PubMed ID: 20206479 [No Abstract] [Full Text] [Related]
38. [Broad-spectrum beta-lactamases in Gram-negative bacteria]. Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424 [TBL] [Abstract][Full Text] [Related]
39. Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. Chmelnitsky I; Hermesh O; Navon-Venezia S; Strahilevitz J; Carmeli Y J Antimicrob Chemother; 2009 Oct; 64(4):718-22. PubMed ID: 19656782 [TBL] [Abstract][Full Text] [Related]
40. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Ariza-Heredia EJ; Patel R; Blumberg EA; Walker RC; Lewis R; Evans J; Sankar A; Willliams MD; Rogers J; Milano C; Razonable RR Transpl Infect Dis; 2012 Jun; 14(3):229-36. PubMed ID: 22624726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]